Search papers, labs, and topics across Lattice.
This paper introduces a closed-loop Bayesian optimization framework for molecular inverse design that leverages a large language model (LLM) as a surrogate to enhance candidate selection. By treating the LLM as the decision-making locus, the method integrates task instructions, optimization history, and oracle feedback in their native textual forms, allowing for a more nuanced exploration of molecular candidates. Experiments demonstrate that this approach outperforms traditional one-shot prompting and competes effectively with Gaussian-process-based baselines, revealing distinct advantages depending on the target type in drug and material design tasks.
Treating a frozen large language model as the decision-maker in molecular design dramatically enhances candidate selection and optimization efficiency.
Practical molecular inverse design is rarely a one-shot generation problem; it often takes the form of closed-loop candidate-pool enrichment, where under a limited oracle budget the goal is to \emph{increase the fraction of generated molecules that match a desired property profile}. Bayesian optimization (BO) offers a natural framework for this setting, yet standard Gaussian-process surrogates typically operate in compressed continuous embeddings, which discard the substructural and reference-similarity signals that chemists naturally use to decide where to look next. We propose \textbf{\method}, a closed-loop framework in which the surrogate, rather than the generator, is treated as the locus of design choice, and instantiate it with a frozen large language model that reasons directly over the task instruction, SMILES-level optimization history, and oracle feedback in their native textual form. At each iteration, the surrogate returns a structured decision signal that selects informative reference molecules under an exploration and exploitation principle, optionally with a concise guidance sentence. This signal is converted into next-round conditioning text for a frozen molecular generator, yielding an inspectable optimization trace in natural language. Experiments on MolQA drug and material design tasks show that \method improves over one-shot prompting, is competitive with or stronger than GP-based BO baselines, and reveals a domain-dependent interface: reference-only transfer works best for binary drug targets, while adding a concise surrogate summary is more beneficial for continuous material
